| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.9 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
-0.009 |
0.9 |
| mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
-0.0088 |
0.9 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.0079 |
0.9 |
| mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |